Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Drug Safety Newsletter 45th Edition

16 December 2011

Topics covered in this edition of the newsletter include:

• Domperidone – Risk of cardiac disorders
• Citalopram and Escitalopram – Risk of QT interval prolongation
• Strattera (atomoxetine) – Effects on blood pressure and heart rate
• Pradaxa (dabigatran etexilate) – Recommendations for assessment of renal function and monitoring in the elderly
• Direct Healthcare Professional Communications published on the IMB website since the last Drug Safety Newsletter

Drug Safety Newsletter 45th Edition

Date Printed: 19 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971